WASHINGTON, United States (AFP) — US biotech company Novavax said Monday it hopes to file for British approval of its Covid-19 vaccine at the start of the second quarter of 2021, and to do the same soon after in the United States. The company has no assurance that US authorities will agree to consider the request, which currently is based on results from Phase 3 clinical trials led in the Britain. Similar trials are still […]